Search Results

Omalizumab in Chronic Spontaneous Urticaria: A Real-World Study on Effectiveness, Safety and Predictors of Treatment Outcome

• Authors : Chen, Jiaoquan; Ou, Shanshan; Wu, Weihong

• Source: Clinical, Cosmetic and Investigational Dermatology. August 31, 2024, Vol. 17, p1799, 9 p.

Record details

Efficacy and Safety of Omalizumab Treatment Over a 16-Year Follow-Up: When a Clinical Trial Meets Real-Life

• Authors : Menzella, Francesco; Fontana, Matteo; Contoli, Marco

• Source: Journal of Asthma and Allergy. April 30, 2022, Vol. 15, p505, 11 p.

Record details

A Pilot Study of Omalizumab to Treat Oxaliplatin-Induced Hypersensitivity Reaction

• Authors : Stein, Stacey; Dooley, Kirsten; Uboha, Nataliya V.

• Source: Oncology. July, 2022, Vol. 36 Issue 7, p414, 6 p.

Record details

Kashiv Reports Enrollment of First Patient in Phase III Clinical Study for ADL018, A Biosimilar Candidate to XOLAIR (omalizumab)

• Source: Health & Beauty Close-Up. October 12, 2023

Record details

Kashiv BioSciences: First Patient Enrolled in Phase III Clinical Study for ADL018, A Biosimilar Candidate to XOLAIR (omalizumab)

• Source: Health & Beauty Close-Up. October 9, 2023

Record details

Real-World Experience on Omalizumab Treatment for Patients with Normocomplementemic Urticarial Vasculitis

• Authors : Liu, Taoming; Bai, Juan; Ying, Shuni

• Source: Journal of Asthma and Allergy. April 30, 2021, Vol. 14, p433, 5 p.

Record details

Chronic Rhinosinusitis with Nasal Polyps: Targeting IgE with Anti-IgE Omalizumab Therapy

• Authors : Kariyawasam, Harsha H.; James, Louisa K.

• Source: Drug Design, Development and Therapy. December 31, 2020, Vol. 14, p5483, 12 p.

Record details

Omalizumab Updosing in Chronic Spontaneous Urticaria: an Overview of Real-World Evidence

• Authors : Metz, Martin; Vadasz, Zahava; Kocatürk, Emek

• Source: Clinical Reviews in Allergy & Immunology. August, 2020, Vol. 59 Issue 1, p38, 8 p.

Record details

Data on Urticaria Reported by Piril Etikan and Colleagues (Depression scores change significantly after omalizumab treatment in patients with chronic spontaneous urticaria)

• Source: Psychology & Psychiatry Journal. July 6, 2024, 116

Record details

Omalizumab for chronic spontaneous urticaria in 'complex' patients: data from real-life clinical practice

• Authors : Vollono, Laura; Piccolo, Arianna; Lanna, Caterina

• Source: Drug Design, Development and Therapy. September, 2019, p3181, 6 p.

Record details